The chart is not accessible to screen readers. Please switch to the table view to access the data.
Advertisement
Advertisement
Changes in forward price to earnings ratios in the global pharmaceutical industry between year-end 2015 and 2016
Changes in forward P/E ratios in the pharmaceutical industry 2015-2016
This statistic displays the change in price to earnings (P/E) ratios in the global pharmaceutical industry on December 31, 2015 and December 31, 2016. According to the source, the change in P/E ratios from 2015 to 2016 was 18.1 to 15.7 or about a 13% decline.
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Percentage return on R&D among large cap biopharma companies 2010-2020
- Premium Statistic Top 10 global pharmaceutical companies by revenue 2025
- Premium Statistic Cost to bring large cap biopharmaceutical assets to market 2010-2020
- Premium Statistic Leading pharmaceutical companies' SG&A to revenue rate 2024
- Premium Statistic Average peak sales forecast per new biopharmaceutical asset 2013-2025
- Premium Statistic Top pharma companies by sales loss due to patent loss until 2018
- Premium Statistic Revenue from pharmaceutical manufacturer in Denmark 2009-2024
- Premium Statistic Total global prescription drug sales of top 10 companies 2026 projection
- Premium Statistic Top U.S. pharmaceutical patent expiries by revenue 2014-2016
- Premium Statistic Average R&D cost to develop new biopharma compound 2013-2025
About the region
10
- Basic Statistic Worldwide Rx drug sales excluding generics and orphan drugs 2012-2026
- Premium Statistic Orphan vs. non-orphan drugs median cost per patient per year 2014-2018
- Premium Statistic Orphan vs. non-orphan pipeline sales forecast worldwide 2025-2030
- Basic Statistic Worldwide share of orphan drug sales by therapy category 2030
- Basic Statistic AstraZeneca's number of animals used for research purposes 2006-2025
- Premium Statistic Total liabilities of the Ipsen group 2014-2019
- Premium Statistic Revenue shares of big pharma as of 2017, by business strategy
- Premium Statistic Top global companies by orphan drug revenues 2024
- Premium Statistic Market cap of select pharma companies with strong pipeline 2017
- Premium Statistic Leading MS pharmaceutical drugs in the U.S. by revenue 2013
Selected statistics
10
- Premium Statistic Pharmaceutical market forecast 2027, by world region
- Premium Statistic Leading UK pharmaceutical and biotechnology companies ranked by market cap 2025
- Premium Statistic Total worldwide prescription drug revenue - projection 2018-2032
- Premium Statistic Patent expiration risk for total worldwide global Rx drug revenue 2018-2032
- Premium Statistic Number of biopharma M&A deals worldwide 2010-2019, by companies
- Basic Statistic Rate of return on biopharma R&D late-stage pipeline 2013-2025
- Premium Statistic Pharmaceutical market size worldwide 2001-2029
- Basic Statistic Leading pharma and biotech companies in 2024, by net sales growth
- Premium Statistic Leading U.S. biotech and pharmaceutical companies 2026, by revenue
- Basic Statistic Spending on R&D from pharmaceutical industry in Canada 2004-2024
Other regions
10
- Basic Statistic Number of applications for drug reimbursement in Denmark 2013-2022
- Basic Statistic Number of declined drug reimbursement applications in Denmark 2013-2022
- Basic Statistic Number of approved drug reimbursement applications in Denmark 2013-2022
- Basic Statistic Profits of pharmaceutical company GlaxoSmithKline Consumer Nigeria 2020
- Premium Statistic Profits of the Nigerian pharmaceutical company Pharma Deko 2020
- Basic Statistic Profits of Nigerian pharmaceutical company Morison Industries 2020
- Basic Statistic Profit of the chemical company May & Baker Nigeria 2020
- Basic Statistic Profits of Nigerian pharmaceutical company Ekocorp 2020
- Basic Statistic Profits of Nigerian company Union Diagnostic Clinical Services 2020
- Basic Statistic Pharmaceutical products manufacturing production value of Sweden 2021-2023
Related statistics
10
- Premium Statistic Distribution of public drug plan spending for drug shortages in Canada 2017-2020
- Basic Statistic Leading pharmaceutical drugs worldwide H1 2025, by sales
- Premium Statistic Leading global mid and small biotech pharma risers based on share price 2022
- Premium Statistic Pharma revenue share forecast worldwide for 2060, by country
- Basic Statistic Global biopharma spending on cold chain transport by mode 2018
- Premium Statistic Clinical phase Alzheimer’s disease drugs 2025, by sponsor
- Premium Statistic Premiums for public U.S. biopharma company trade sales 2010-2019
- Basic Statistic Pharmaceutical excipients global market size 2023 vs forecast 2032
- Premium Statistic Employee and CEO compensation growth biotech pharma 2017-2018
- Premium Statistic Size of U.S. CRO market 2024 vs. 2031
Further Content: You might find this interesting as well
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
KPMG. (January 12, 2017). Changes in forward price to earnings ratios in the global pharmaceutical industry between year-end 2015 and 2016 [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 28, 2026, from /statistics/747530/changes-in-forward-price-to-earnings-ratios-in-the-pharma-industry/
KPMG. "Changes in forward price to earnings ratios in the global pharmaceutical industry between year-end 2015 and 2016." Chart. January 12, 2017. ÌÇÐÄÆƽâ°æ. Accessed July 28, 2026. /statistics/747530/changes-in-forward-price-to-earnings-ratios-in-the-pharma-industry/
KPMG. (2017). Changes in forward price to earnings ratios in the global pharmaceutical industry between year-end 2015 and 2016. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 28, 2026. /statistics/747530/changes-in-forward-price-to-earnings-ratios-in-the-pharma-industry/
KPMG. "Changes in Forward Price to Earnings Ratios in The Global Pharmaceutical Industry between Year-end 2015 and 2016." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 12 Jan 2017, /statistics/747530/changes-in-forward-price-to-earnings-ratios-in-the-pharma-industry/
KPMG, Changes in forward price to earnings ratios in the global pharmaceutical industry between year-end 2015 and 2016 ÌÇÐÄÆƽâ°æ, /statistics/747530/changes-in-forward-price-to-earnings-ratios-in-the-pharma-industry/ (last visited July 28, 2026)
Changes in forward price to earnings ratios in the global pharmaceutical industry between year-end 2015 and 2016 [Graph], KPMG, January 12, 2017. [Online]. Available: /statistics/747530/changes-in-forward-price-to-earnings-ratios-in-the-pharma-industry/
Advertisement